About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT03893643

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000. the clinical pres...

Lead sponsor: Centre Hospitalier Universitaire de Nice•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Sophie LEGOUPIL

CONTACT

336 81818020 sophie.legoupil@hotmail.fr

Christine CHIAVERINI

CONTACT

chiaverini.c@chu-nice.fr

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nice

Age

0 - 15 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age up to 15 years
•diagnosis of neurofibromatosis type 2

Exclusion Criteria

•refusal to participate in the study
•informed consent that can not be obtained because of a disability or difficulties with a - language barrier

Related studies

Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

NCT06724627 · Skin Condition, Dermatology, and more

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

NCT03406208 · Neurofibromatoses, Neurofibromatosis 1, and more

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

NCT05685836 · Neurofibromatosis 2

Vestibular Precision: Physiology & Pathophysiology

NCT04890132 · Vestibular Schwannoma, Inner Ear Disease, and more

Skin Tone Preferences and Their Influence on Skin Care Behaviors

NCT03651167 · Dermatology/Skin - Other

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 28, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,000

Start dateJan 2019

Last updatedMar 28, 2019

Condition

Neurofibromatosis 2 Dermatology/Skin - Other

Locations shown

Nice Hospital

Nice

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions